Novosibirsk · Russian-qualified counsel Recognised by Pravo-300 · Best Lawyers · Kommersant
Uzbekistan · Analysis

Alert: important development in data protection and localisation requirements in Uzbekistan in the pharmaceuticals sector

Nodira Yusupova · September 2026 · 3 min read

Uzbekistan has tightened data localisation rules for pharmaceutical companies. Foreign operators must act before the compliance window closes. Make an enquiry.

Alert: important development in data protection and localisation in Uzbekistan — pharmaceuticals sector Effective: 27 August 2027

Uzbekistan has moved to strengthen enforcement of its personal data localisation requirements under the framework governing data protection for pharmaceutical operators. Foreign pharmaceutical companies — including manufacturers, distributors, and clinical research organisations — that collect, process, or transfer personal data of Uzbekistan residents in connection with their commercial or regulatory activities in the country are directly in scope. The development tightens the obligation to store qualifying personal data on servers physically located within Uzbekistan and introduces a more structured supervisory mechanism for sector-specific compliance verification.

Foreign pharmaceutical operators with existing Uzbekistan operations, registration processes, or distribution arrangements face the most immediate exposure. The rules apply to personal data processed in connection with clinical trials, pharmacovigilance reporting, patient and healthcare provider records, and distributor or employee data. Companies that have historically relied on server infrastructure located in Russia, the EU, or third-country cloud environments to process Uzbekistan-resident data will need to assess whether their current arrangements satisfy the localisation standard. The supervisory authority responsible for data protection in Uzbekistan has indicated that sector-specific inspections of pharmaceutical operators are a stated enforcement priority for the current period, which materially increases the practical risk of non-compliance being detected and acted upon.

Recommended action:

Practitioner note

This briefing is general information and does not constitute legal advice. For advice on a specific matter, write in confidence to info@vetrovpartners.com.

Facing a matter like this?

Our team advises foreign clients on exactly these questions across Russia and the EAEU region. Initial 30-minute consultation — complimentary.

Make an enquiry